Evaxion A (EVAX) Current Deferred Tax Assets (2020 - 2022)
Evaxion A (EVAX) reported Current Deferred Tax Assets of $87000.0 for Q2 2022, down 67.17% on a YoY basis from $265000.0 in Q2 2021, and up 770.0% quarter-over-quarter from $10000.0 in Q1 2022.
Evaxion A (EVAX) Current Deferred Tax Assets (2020 - 2022) Analysis & Trends
Evaxion A has reported Current Deferred Tax Assets for 3 years, with the latest figure at $87000.0 in Q2 2022.
- For the quarter ending Q2 2022, Current Deferred Tax Assets fell 67.17% year-over-year to $87000.0; the trailing twelve-month figure through Jun 2022 stood at $87000.0 (down 67.17% YoY), and the FY2020 full-year result was $1.7 million, changed N/A from the prior year.
- Current Deferred Tax Assets for Q2 2022 stood at $87000.0, up from $10000.0 in the prior quarter.
- The five-year high for Current Deferred Tax Assets was $1.7 million in Q4 2020, with the low at $10000.0 in Q1 2022.
- Historically, Current Deferred Tax Assets has averaged $509600.0 across 3 years, with a median of $265000.0 in 2021.
- The largest YoY upside for Current Deferred Tax Assets was 67.17% in 2022 against a maximum downside of 67.17% in 2022.
- Evaxion A's Current Deferred Tax Assets stood at $1.7 million in 2020, then plunged by 73.57% to $457000.0 in 2021, then plunged by 80.96% to $87000.0 in 2022.
- The last three Current Deferred Tax Assets figures came in at $87000.0 (Q2 2022), $10000.0 (Q1 2022), and $457000.0 (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 87,000.00 |
| Jun 30, 2022 | 87,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Sep 30, 2021 | 457,000.00 |
| Sep 30, 2021 | 457,000.00 |
| Jun 30, 2021 | 265,000.00 |
| Jun 30, 2021 | 265,000.00 |
| Dec 31, 2020 | 1.73 Mn |
| Dec 31, 2020 | 1.73 Mn |